Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Tax-Provision" stands at 1.88 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 0.68 Billion EUR for the item "Tax Provision" represents a decrease of -4.36 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 0.68 Billion EUR for the item "Tax Provision" represents a decrease of -7.73 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 1.88 Billion EUR for the item "Tax Provision" represents a decrease of -2.95 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 24.32 percent compared to the value the year prior.
The 1 year change in percent is 24.32.
The 3 year change in percent is 37.54.
The 5 year change in percent is 39.79.
The 10 year change in percent is 59.93.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Tax Provision | 905,699,262,464.00 |
![]() | Johnson & Johnson - Tax Provision | 486,508,953,600.00 |
![]() | AbbVie Inc - Tax Provision | 399,570,305,024.00 |
![]() | Roche Holding AG - Tax Provision | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Tax Provision | 280,205,508,085.11 |